Other authors that assessed the levels of IL-6 in cervical cancer tissues and adjacent non-tumor tissues found higher expression in cervical cancer tissues [27, 32], suggesting its role as a biomarker for the prognosis and therapy of cervical cancer [32]. The gene discussed is IL6; the disease is neoplasm.